SARS-CoV-2 triggered relapse of multiple sclerosis-Reference-Cited by-同舟云学术

SARS-CoV-2 triggered relapse of multiple sclerosis

Published:2022-04 Issue: Volume:215 Page:107210
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Finsterer Josef

Publisher

Elsevier BV

Subject

Neurology (clinical),General Medicine,Surgery

Reference17 articles.

1. COVID-19: pulmonary and extra pulmonary manifestations;Elrobaa;Front. Public Health,2021

2. Extrapulmonary onset manifestations of COVID-19;Finsterer;Clinics,2021

3. Neuropathogenesis of severe acute respiratory syndrome coronavirus 2;Patel;Curr. Opin. Pediatr.,2021

4. Neurological manifestations and outcomes in a retrospective cohort of Mexican Inpatients with SARS-CoV-2 pneumonia: design of a risk profile;García,2021

5. Presentation of neuro-COVID is broad and pathogenesis diverse;Finsterer;West J. Emerg. Med.,2021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Report: New-onset relapsing-remitting multiple sclerosis with positive Uhthoff phenomenon after second BNT162b2 dose;F1000Research;2024-08-20

2. Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis;BMC Immunology;2024-06-19

3. A case of early disease rebound after fingolimod discontinuation in a patient with multiple sclerosis and SARS-CoV-2 infection;Neurological Sciences;2024-03-28

4. Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study;Vaccines;2023-12-16

5. COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study;Journal of Neurology, Neurosurgery & Psychiatry;2023-10-19